Ebright Lab

Dr. Ebright weighs in on underlying biosecurity pitfalls of bioweapons research amid recent Anthrax mishap

Dr. Richard Ebright has been featured in several media outlets as a molecular biologist and biosecurity expert:

Rutgers Gets up to $26 Million Grant to Lead Development of New Antibiotics

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has selected infectious disease expert David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, to lead a major research effort aimed at developing new forms of antibiotics to regain the upper hand over deadly bacteria that have become resistant to current treatments.   

National Institutes of Health MERIT Award

Richard Ebright, Board of Governors professor in the Department of Chemistry and Chemical Biology at the School of Arts and Sciences and laboratory director at the

Dr. Richard H. Ebright

Principal Investigator

Transcription--synthesis of an RNA copy of genetic information in DNA--is the first step in gene expression and is the step at which most regulation of gene expression occurs. Richard H. Ebright's lab seeks to understand structures, mechanisms, and regulation of bacterial transcription complexes and to identify, characterize, and develop small-molecule inhibitors of bacterial transcription for application as antituberculosis agents and broad-spectrum antibacterial agents.